Surgical vs Endoscopic Management of T1 Esophageal Adenocarcinoma: A Modeling Decision Analysis-Reference-Cited by-同舟云学术

Surgical vs Endoscopic Management of T1 Esophageal Adenocarcinoma: A Modeling Decision Analysis

Published:2018-03 Issue:3 Volume:16 Page:392-400.e7
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Chu Jacqueline N.^ORCID,Choi Jin,Tramontano Angela,Morse Christopher,Forcione David,Nishioka Norman S.,Abrams Julian A.,Rubenstein Joel H.,Kong Chung Yin,Inadomi John M.^ORCID,Hur Chin^ORCID

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference34 articles.

1. Treatment trends, risk of lymph node metastasis, and outcomes for localized esophageal cancer;Merkow;J Natl Cancer Inst,2014

2. Esophageal cancer;Enzinger;N Engl J Med,2003

3. Esophageal and esophagogastric junction cancers. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): National Comprehensive Cancer Network, 2017.

4. Long-term efficacy and safety of endoscopic resection for patients with mucosal adenocarcinoma of the esophagus;Pech;Gastroenterology,2014

5. Curative endoscopic resection of early esophageal adenocarcinomas (Barrett's cancer);Ell;Gastrointest Endosc,2007

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictors for lymph node metastasis and survival of patients with T1b esophageal adenocarcinoma treated with surgery and endoscopic therapy: an analysis of the Surveillance, Epidemiology, and End Results database;Gastrointestinal Endoscopy;2024-05

2. Diagnosis and Management of Barrett’s Esophagus;Journal of Clinical Medicine;2023-03-09

3. The economic burden of esophageal cancer in Iran;Indian Journal of Cancer;2022-10

4. Pushing the boundaries of endoscopic management of early-stage esophageal adenocarcinoma: Caution is advisable!;Gastrointestinal Endoscopy;2022-08

5. A cost-effectiveness modeling study of treatment interventions for stage I to III esophageal squamous cell carcinoma;Cost Effectiveness and Resource Allocation;2022-04-02